,i  #aafth ,,congress  #ast ,session    
,h4 ,r4 #echa  ,,in ,,the ,,house ,,of  
,,representatives  ,december #aj1       
#bjai,mr4 ,des,jarlais introduced the   
following bill2 which was referred to   
the ,committee on ,energy and ,commerce 
,a ,,bill  ,to amend the ,federal ,food1
 ,drug1 and ,cosmetic ,act to require   
the label of a drug to list the country 
of origin of each of the drug's active  
ingredients4  #a4 ,short title ,this    
,act may be cited as the ,international 
,pharmaceutical ,transparency ,act of   
#bjai4  #b4 ,country-of-origin labeling 
for active ingredients in drugs  7a7    
,misbranding ,section #ejb of the       
,federal ,food1 ,drug1 and ,cosmetic    
,act 7#ba ,u4,s4,c4 #ceb7 is amended by 
adding at the end the following3  7ee7  
,if it is a drug and its label fails to 
list the country of origin of each of   
its active ingredients4  4  7b7         
,applicability ,section #ejb7;ee7 of the
 ,federal ,food1 ,drug1 and ,cosmetic   
,act1 as added by subsection 7a71       

applies beginning on the day that is #f 
months after the date of enactment of   
this ,act4